Drug eruptions

Medicine

Volumn 37, Issue 5, 2009, Pages 263-266

  Coulson, Ian H ^a  

^a North East Lancashire Acute Hospitals Trust ^*  (United Kingdom)

Author keywords

drug reactions; eosinophilia; pustular eruption; Stevens Johnson syndrome; toxic epidermal necrolysis

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ALLOPURINOL; AMLODIPINE; AMOXICILLIN; AMPICILLIN; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CEPHALOSPORIN; COTRIMOXAZOLE; COUMARIN; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EMOLLIENT AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GENTAMICIN; HEPARIN; HYDROXYUREA; NICORANDIL; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PENICILLIN G; PHENOLPHTHALEIN; QUINIDINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; TETRACYCLINE; UNINDEXED DRUG;

ACNE; ALOPECIA; ANAMNESIS; ANGIONEUROTIC EDEMA; ANUS ULCER; APHTHOUS STOMATITIS; CROSS REACTION; DISEASE CLASSIFICATION; DRESS SYNDROME; DRUG ERUPTION; DRUG MEGADOSE; DRUG POTENCY; DRUG WITHDRAWAL; ECZEMA; ERYTHROCYTE TRANSFUSION; EYEBROW TRICHOMEGALY; EYELASH TRICHOMEGALY; HUMAN; HYPOTHYROIDISM; LEG PAIN; LEUKOCYTOCLASTIC VASCULITIS; LICHENOID ERUPTION; LOW DRUG DOSE; LYMPHOCYTE TRANSFORMATION TEST; MEASLES LIKE RASH; PARONYCHIA; PATCH TEST; PATIENT ASSESSMENT; PATIENT REFERRAL; PERIVULVAL ULCER; PHOTOSENSITIVITY; PRIORITY JOURNAL; PSORIASIS; RADIOALLERGOSORBENT TEST; REVIEW; SCALP ALOPECIA; SKIN APPENDAGE DISEASE; SKIN NECROSIS; SKIN ULCER; SMALL VESSEL VASCULITIS; STEVENS JOHNSON SYNDROME; TOE ULCER; TOXIC EPIDERMAL NECROLYSIS; URTICARIA;

EID: 65549112500     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpmed.2009.02.004     Document Type: Review

References (8)

1. Bigby M., Jick S., Jick H., and Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. J Am Med Assoc 256 (1986) 3358-3363
2. MHRA. Targeted healthcare providers group/ Available at: http://www.mhra.gov.uk/Safetyinformation/Healthcareproviders/index.htm (accessed 3 January 2009).
3. Litt J.Z. Litt's drug eruption reference manual. 12th edn. (2006), Informa Healthcare, Oxford
4. Byrd J.B., Adam A., and Brown N.J. Angiotensin-converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin North Am 26 (2006) 725-737
5. Toquero L., Briggs C.D., Bassuini M.M., and Rochester J.R. Anal ulceration associated with Nicorandil: case series and review of the literature. Colorectal Dis 8 (2006) 717-720
6. Bianchini D., Jayanth A., Chua Y.J., and Cunningham D. Epidermal growth factor receptor inhibitor-related skin toxicity: mechanisms, treatment, and its potential role as a predictive marker. Clin Colorectal Cancer 7 (2008) 33-43
7. Mukasa Y., and Craven N. Management of toxic epidermal necrolysis and related syndromes. Postgrad Med J 84 (2008) 60-65
8. Tas S., and Simonart T. Management of drug rash with eosinophilia with systemic symptoms. Dermatology 206 (2003) 353-356